Pierre-Henri Baviera

Pierre-Henri Baviera is an accomplished executive with extensive experience in leadership roles across various sectors. Currently serving as the Chief Executive Officer at MIAS Pharma Limited since September 2022, Baviera previously held the same position at Derilinx and Presidion, where responsibilities included developing and executing growth strategies with full P&L accountability. Notable achievements include transforming Presidion from a UK and Ireland-based advanced analytics software resell business to a pan-European advanced analytics solution provider. Earlier career experience includes roles at Pathfinder Consulting, PA Consulting, Cap Gemini Ernst and Young, and H3 Technology, focusing on technology, data analytics, and management consulting. Pierre-Henri Baviera holds an MBA from University College Dublin and degrees in Electrical and Computer Engineering and Maths and Physics from CentraleSupélec and Paris-Sud University, respectively.